Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.73)
# 795
Out of 4,749 analysts
137
Total ratings
55.3%
Success rate
5.88%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $294.21 | +27.46% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $10.16 | +18.11% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $64.03 | +32.75% | 17 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Outperform | $610 → $640 | $542.49 | +17.97% | 14 | Dec 6, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $26.47 | +39.78% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $329.91 | +21.25% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $139.66 | +20.29% | 8 | Oct 25, 2024 | |
| HUM Humana | Maintains: Outperform | $400 → $280 | $293.23 | -4.51% | 12 | Oct 3, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $125.16 | +15.85% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $14.53 | +175.29% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.20 | +56.25% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $8.40 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $562.00 | +15.66% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $92.50 | +56.76% | 10 | Oct 28, 2022 |
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $294.21
Upside: +27.46%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $10.16
Upside: +18.11%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $64.03
Upside: +32.75%
UnitedHealth Group
Dec 6, 2024
Maintains: Outperform
Price Target: $610 → $640
Current: $542.49
Upside: +17.97%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $26.47
Upside: +39.78%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $329.91
Upside: +21.25%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $139.66
Upside: +20.29%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400 → $280
Current: $293.23
Upside: -4.51%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $125.16
Upside: +15.85%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $14.53
Upside: +175.29%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.20
Upside: +56.25%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $8.40
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $562.00
Upside: +15.66%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $92.50
Upside: +56.76%